Evangelismos S.A.

The medical center is at the forefront of research in hematological malignancies, focusing on innovative therapies for conditions such as Chronic Lymphocytic Leukemia, Multiple Myeloma, and Acute Lymphoblastic Leukemia. The center's work in this field aims to improve patient outcomes through novel treatment combinations and targeted therapies.

• Chronic Lymphocytic Leukemia (CLL)
• Multiple Myeloma
• Acute Lymphoblastic Leukemia (ALL)

By integrating cutting-edge research with clinical practice, the center is enhancing the efficacy and safety of treatments for these complex diseases.

Specializing in autoimmune and inflammatory diseases, the center conducts pioneering research on conditions like Ulcerative Colitis, Thrombotic Thrombocytopenic Purpura, and Discoid Lupus Erythematosus. The focus is on developing therapies that modulate the immune response to alleviate symptoms and improve quality of life.

• Ulcerative Colitis
• Thrombotic Thrombocytopenic Purpura (TTP)
• Discoid Lupus Erythematosus

Through its research, the center is advancing the understanding of these diseases and contributing to the development of more effective treatment strategies.

The center is a leader in the study of infectious diseases and immunology, with a particular emphasis on conditions such as COVID-19 and Chronic Hepatitis B. Research efforts are directed towards understanding disease mechanisms and developing vaccines and antiviral therapies.

• COVID-19
• Chronic Hepatitis B

By leveraging its expertise in immunology, the center is making significant contributions to global health through the development of innovative treatments and preventive measures.

Focusing on respiratory and pulmonary disorders, the center is engaged in groundbreaking research on diseases such as Pulmonary Arterial Hypertension and Idiopathic Pulmonary Fibrosis. The aim is to enhance therapeutic options and improve patient outcomes through novel drug development and clinical trials.

• Pulmonary Arterial Hypertension (PAH)
• Idiopathic Pulmonary Fibrosis (IPF)

The center's research is pivotal in advancing the understanding and treatment of these challenging conditions, offering hope to patients worldwide.

In the realm of endocrine and metabolic disorders, the center is pioneering research on conditions like Cushing Syndrome and Congenital Adrenal Hyperplasia. The focus is on developing therapies that address hormonal imbalances and metabolic dysfunctions.

• Cushing Syndrome
• Congenital Adrenal Hyperplasia (CAH)

Through its innovative research, the center is contributing to the development of treatments that improve metabolic health and patient quality of life.